Evidence map›Paper›PMID 33770268›Full record

ArticleWiener klinische Wochenschrift2021

New insights from GINA 2019/2020-Focus on early anti-inflammatory therapy.

Marco Idzko, Sylvia Hartl, Bernd Lamprecht, Matthias Reisinger, Judith Löffler-Ragg, Markus Rauter, Michael Studnicka, Wolfgang Pohl

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

Marco IdzkoDepartment of Pneumology, Internal Medicine II, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. marco.idzko@meduniwien.ac.at.
Sylvia HartlII. Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital, Vienna, Austria.
Bernd LamprechtDepartment for Pulmonary Medicine, Johannes Kepler University Linz, Linz, Austria.
Matthias ReisingerLung specialist, Bad Ischl, Austria.
Judith Löffler-RaggDepartment of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.
Markus RauterDepartment of Pulmonology, Klinikum Klagenfurt, Klagenfurt, Austria.
Michael StudnickaPneumology, Paracelsus Medical University, Salzburg, Austria.
Wolfgang PohlDepartment of Respiratory and Lung Diseases, Hietzing Hospital, Karl Landsteiner Institute for Experimental and Clinical Pulmonology, Vienna, Austria.
Innsbruck Medical University · ATJohannes Kepler University of Linz · ATKlinik Hietzing · ATKlinikum Klagenfurt · ATMAS Alzheimerhilfe · ATMedical University of Vienna · ATOtto Wagner Hospital · ATParacelsus Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaAnti-Inflammatory AgentsHumansAnti-Inflammatory Agents

Identifiers

PMID33770268
OpenAlexW3137922563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.